Tetrahydrozoline ophthalmic Interactions
There are 49 drugs known to interact with tetrahydrozoline ophthalmic, along with 4 disease interactions. Of the total drug interactions, 6 are major, and 43 are moderate.
- View all 49 medications that may interact with tetrahydrozoline ophthalmic
- View tetrahydrozoline ophthalmic disease interactions (4)
Most frequently checked interactions
View interaction reports for tetrahydrozoline ophthalmic and the medicines listed below.
- Advair HFA (fluticasone / salmeterol)
- Ancef (cefazolin)
- Aspirin Low Strength (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Benadryl (diphenhydramine)
- BuSpar (buspirone)
- Celexa (citalopram)
- Cialis (tadalafil)
- Claritin (loratadine)
- Colace (docusate)
- Depakote (divalproex sodium)
- Dulcolax (bisacodyl)
- Eliquis (apixaban)
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- Imodium (loperamide)
- Keflex (cephalexin)
- Lasix (furosemide)
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- Milk of Magnesia (magnesium hydroxide)
- MiraLAX (polyethylene glycol 3350)
- Pataday (olopatadine ophthalmic)
- Prilosec (omeprazole)
- Prozac (fluoxetine)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Voltaren Arthritis Pain Gel (diclofenac topical)
- Zyrtec (cetirizine)
Tetrahydrozoline ophthalmic disease interactions
There are 4 disease interactions with tetrahydrozoline ophthalmic which include:
Report options
QR code containing a link to this page
More about tetrahydrozoline ophthalmic
- tetrahydrozoline ophthalmic consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic antihistamines and decongestants
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.